ErbB2 without erbB3 expression in metaplastic columnar epithelium of Barrett's esophagus

Digestion

Volumn 70, Issue 2, 2004, Pages 95-102

  Nishigaki, Hitoshi ^a   Wada, Ken ^a   Tatsuguchi, Atsushi ^a   Sueoka, Nobuo ^a   Futagami, Seiji ^a   Gudis, Katya ^a   Miyake, Kazumasa ^a   Tsukui, Taku ^a   Sakamoto, Choitsu ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Barrett's esophagus; EGF receptor; erbB2; erbB3; Intestinal metaplasia

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; METHYLENE BLUE;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; BIOPSY; CLINICAL ARTICLE; COLUMNAR EPITHELIUM; CONTROLLED STUDY; ENDOSCOPY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS EPITHELIUM; STAINING; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; BLOTTING, WESTERN; ENDOSCOPES, GASTROINTESTINAL; EPITHELIUM; ESOPHAGUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; METAPLASIA; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3;

EID: 5644273804     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080928     Document Type: Article

References (36)

1. Miettinen PJ: Transforming growth factor-alpha and epidermal growth factor expression in human fetal gastrointestinal tract. Pediatr Res 1993;33:481-486.
2. Playford RJ, Wright NA: Why is epidermal growth factor present in the gut lumen? Gut 1996;38:303-305.
3. Konturek PC, Ernst H, Brzozowski T, Ihlm A, Hahn EG, Konturek SJ: Expression of epidermal growth factor and transforming growth factor-alpha after exposure of rat gastric mucosa to stress. Scand J Gastroenterol 1996;31:209-216.
4. Konturek JW, Hengst K, Konturek SJ, Domschke W: Epidermal growth factor in gastric ulcer healing by nocloprost, a stable prostaglandin E2 derivative. Scand J Gastroenterol 1997;32:980-984.
5. Urbie JM, Barrett KE: Nonmitogenic actions of growth factors: An integrated view of their role in intestinal physiology and pathophysiology. Gastroenterology 1997;112:255-268.
6. Ozawa S, Ueda M, Ando N, Shimizu N, Abe O: Prognostic significance of epidermal growth factor receptor in esophageal squamous cell carcinoma. Cancer 1989;63:2169-2173.
7. Mukaida H, Toi M, Hirai T, Yamashita Y, Togo T: Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancer. Cancer 1991;68:142-148.
8. Yano H, Shiozaki H, Kobayashi K, Yano T, Tahara H, Tamura S, Mori T: Immunohistologic detection of the epidermal growth factor receptor in human esophagus: Squamous cell carcinoma. Cancer 1991;67:91-98.
9. Jankowski J, Hopwood D, Wormsley KG: Flow-cytometric analysis of growth-regulatory peptides and their receptors in Barrett's oesophagus and oesophageal adenocarcinoma. Scand J Gastroenterol 1992;27:147-154.
10. Filipe MI, Jankowski J: Growth factors and oncogenes in Barrett's oesophagus and gastric metaplasia. Endoscopy 1993;25:637-641.
11. Jankowski J, Hopwood D, Pringle R, Wormsley KG: Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis. Am J Gastroenterol 1993;88:402-408.
12. Yacoub L, Goldman H, Odze RD: Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett'sassociated neoplasia: Correlation with prognosis. Mod Pathol 1997;10:105-112.
13. Polkowski W, van Sandick JW, Offerhaus GJ, ten kate FJ, Mulder J, Obertop H, van Lanschot JJ: Prognostic value of Lauren classification and c-erbB2 oncogene expression in adenocarcinoma of the esophagus and gastroesophageal junction. Ann Surg Oncol 1999;6:290-297.
14. Prigent SA, Lemoine NR, Hughes CM, Plowman GD, Gullick WJ: Expression of the cerbB-3 protein in normal adult and fetal tissues. Oncogene 1992;7:1273-1278.
15. Rajkumar T, Goden CSR, Lemoine NR, Gullick WJ: Expression of the c-erbB-3 protein in gastrointestinal tract tumours determined by monoclonal antibody RTJ1. J Pathol 1993;170:271-278.
16. Friess H, Fukuda A, Tang WH, Eichenberger A, Furlan N, Zimmermann A, Korc M, Buchler MW: Concomitant analysis of the epidermal growth factor receptor family in esophageal cancer: Overexpression of epidermal growth factor receptor mRNA but of c-erbB-2 and cerbB-3. World J Surg 1999;23:1010-1018.
17. Paull A, Treir J, Dalton M: The histological spectrum of Barrett's esophagus. N Engl Med 1976;296:476-480.
18. Potet F, Duchatelle V: Barrett's oesophagus. Curr Top Pathol 1990;81:43-60.
19. Spechler SJ, Goyal RK: Barrett's esophagus. N Engl Med 1986;315:362-371.
20. Spechler SJ, Goyal RK: The columnar-lined esophagus, intestinal metaplasia and normal Barrett. Gastroenterology 1996;110:614-621.
21. Devesa SS, Blot WJ, Fraumeni JF Jr: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-2053.
22. Bollschweiler E, Wolfgarten E, Gutschow C, Holscher AH: Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001;92:549-555.
23. Sueoka N, Nishigaki H, Yonezawa M, Tsukui T, Sakamoto C, Tabuchi M: Usefullness of double dye staining (methylene blue and crystal violet) for the magnifying observation of intestinal metaplasia in Barrett's esophagus (abstract). Gastrointest Endosc 2000;51:AB117.
24. Prach AT, MacDonald TA, Hopwood DA, Johnston DA: Increasing incidence of Barrett's oesophagus: Education, enthusiasm, or epidemiology? (letter). Lancet 1997;350:933.
25. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinmeister AR: Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-513.
26. Nakamura T, Nekarda H, Hoelscher AH, Bollschweiler E, Horbec N, Becker K, Siewert JR: Prognostic value of DNA ploidy and cerbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus. Cancer 1994;73:1785-1794.
27. Flejou J-F, Paraf F, Muzeau F, Fekete F, Henin D, Jothy S, Potet F: Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: Pathological and prognostic correlations. J Clin Pathol 1994;47:23-26.
28. Hardwick RH, Shephered NA, Moorghen M, Newcomb PV, Alderson D: c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus. J Clin Pathol 1995;48:129-132.
29. Kim R, Clarke MR, Melhem MF, Young MA, Vanbibber MM, Safatle-Ribeiro AV, Ribeiro U Jr, Reynolds JC: Expression of p53, PCNA, and C-erbB-2 in Barrett's metaplasia and adenocarcinoma. Dig Dis Sci 1997;42:2453-2462.
30. Bhargava P, Eisen GM, Holterman DA, Azumi A, Hartman DP, Hanfelt JJ, Benjamin SB, Lippman ME, Montgomery EA: Endoscopic mapping and surrogate markers for better surveillance in Barrett's esophagus: Study of 700 biopsy specimens. Am J Clin Pathol 2000;114:552-563.
31. Jankowski J, McMenemin R, Hopwood D, Penston J, Wormsley KG: Abnormal expression of growth regulatory factors in Barrett's oesophagus. Clin Sci (Lond) 1991;81:663-668.
32. Brito MJ, Filipe MI, Linehan J, Jankowski J: Association of transforming growth factor alpha (TGFA) and its precursors with malignant change in Barrett's epithelium: biological and clinical variables. Int J Cancer 1995;60:27-32.
33. Cohen JA, Weiner DB, More KF, Kokai Y, Williams WV, Maguire HC Jr, LiVolsi VA, Greene MI: Expression pattern of the neu(NGL)gene-encoded growth factor receptor protein(p185neu) in normal and transformed epithelial tissues of the digestive tract. Oncogene 1989;4:81-88.
34. Venter DJ, Tuzi NL, Kumar S, Gullick WJ: Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: Immunohistological assessment correlates with gene amplification. Lancet 1987;ii:69-72.
35. Carraway KL III, Siwkowski MX, Akita R, Platoko JV, Guy PM, Nuijens A, Diamonti AJ, Vandlen RL, Cantley LC, Cerione RA: The erbB3 gene product is a receptor for heregulin. J Biol Chem 1994;269:14303-14306.
36. Noguchi H, Sakamoto C, Wada K, Akamatsu T, Uchida T, Tatsuguchi A, Matsui H, Fukui H, Fujimori T, Kasuga M: Expression of heregulin, erbB2, and erbB3 and their influences on proliferation of gastric epithelial cells. Gastroenterology 1999;117:1119-1127.